Evaluation of rotigotine transdermal patch for the treatment of apathy and motor symptoms in Parkinson’s disease

被引:0
作者
Robert A Hauser
Jaroslaw Slawek
Paolo Barone
Elisabeth Dohin
Erwin Surmann
Mahnaz Asgharnejad
Lars Bauer
机构
[1] USF Health – Byrd Institute,Parkinson’s Disease and Movement Disorders Center
[2] National Parkinson Foundation Center of Excellence,Department of Neurological–Psychiatric Nursing
[3] Medical University of Gdańsk and Department of Neurology,Neurodegenerative Disease Center
[4] St Adalbert Hospital,undefined
[5] University of Salerno,undefined
[6] UCB Pharma,undefined
[7] UCB Pharma,undefined
[8] UCB Pharma,undefined
来源
BMC Neurology | / 16卷
关键词
Apathy; Parkinson’s disease; Rotigotine transdermal patch; Treatment;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
相关论文
共 125 条
[1]  
Starkstein SE(2008)The nosological position of apathy in clinical practice J Neurol Neurosurg Psychiatry 79 1088-92
[2]  
Leentjens AF(2011)Is apathy a valid and meaningful symptom or syndrome in Parkinson’s disease? A critical review Health Psychol 30 386-400
[3]  
Bogart KR(2015)Apathy in Parkinson’s disease: a systematic review and meta-analysis Mov Disord 30 759-69
[4]  
den Brok MG(2015)The association between fatigue and apathy in patients with either Parkinson’s disease or multiple sclerosis Parkinsonism Relat Disord 21 1093-5
[5]  
van Dalen JW(2009)The PRIAMO study: a multicenter assessment of nonmotor symptoms and their impact on quality of life in Parkinson’s disease Mov Disord 24 1641-9
[6]  
van Gool WA(2012)The progression of non-motor symptoms in Parkinson’s disease and their contribution to motor disability and quality of life J Neurol 259 2621-31
[7]  
van Charante EP M(2015)Apathy in Parkinson’s disease: clinical features, neural substrates, diagnosis, and treatment Lancet Neurol 14 518-31
[8]  
de Bie RM(2012)Dopamine pathway loss in nucleus accumbens and ventral tegmenal area predicts apathetic behavior in MPTP-lesioned monkeys Exp Neurol 236 190-7
[9]  
Richard E(2015)An update on pharmacological, pharmacokinetic properties and drug-drug interactions of rotigotine transdermal system in Parkinson’s disease and restless legs syndrome Drugs 75 487-501
[10]  
Cochrane GD(2011)Rotigotine effects on early morning motor function and sleep in Parkinson’s disease: a double-blind, randomized, placebo-controlled study (RECOVER) Mov Disord 26 90-9